CAS 189691-06-3: PT-141
Formula:C50H68N14O10
InChI:InChI=1/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41?/m0/s1
Synonyms:- Bremelanotide
- Brmelanotice
- Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH
- (3S,6S,9R,12S,23S)-15-[(N-acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid
- Brmelanotide
- Pt141
- Bromelanotide
Sort by
Found 5 products.
Bremelanotide Acetate Hydrate
CAS:Controlled ProductStability Hygroscopic Applications Bremelanotide is a melanocortin receptor agonist shown to improve female sexual function in females suffering from sexual dysfunction. References Safarinejad, M. et al.: J. Sex. Med., 50, 887 (2008); Pfaus, J. et al.: J. Sex. Med., 4, 269 (2007);Formula:C52H74N14O13Color and Shape:NeatMolecular weight:1103.23L-Lysine, N-acetyl-L-norleucyl-L-α-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, (2→7)-lactam
CAS:Formula:C50H68N14O10Purity:≥97%Molecular weight:1025.1627Bremelanotide
CAS:Bremelanotide is a synthetic peptide analog of alpha-MSH and is an agonist at melanocortin receptors including the MC3R and MC4R.Formula:C50H68N14O10Purity:98%Color and Shape:White PowderMolecular weight:1025.16Bremelanotide
CAS:Bremelanotide is a synthetic cyclic peptide that is used for the treatment of female sexual dysfunction. It affects the physiological effects of sexual arousal by increasing blood flow to sexually sensitive tissue, and it has been shown to be effective in women with hypoactive sexual desire disorder as well as those who have not responded to other treatments. Bremelanotide binds to melanocortin receptors, which are expressed in the brain, on genital skin and in the pituitary gland. The drug has no significant interactions with other drugs and has a short half-life, making it suitable for use as an on-demand treatment.Formula:C50H68N14O10Purity:Min. 95%Color and Shape:White PowderMolecular weight:1,025.16 g/mol
